Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adam Spence is a specialized manufacturer of high-precision medical tubing and catheter components for the healthcare industry. The company provides comprehensive contract manufacturing services, including advanced extrusion, braiding, and assembly of reinforced catheter shafts. Their expertise focuses on high-performance polymers and complex geometries required for minimally invasive surgical instruments. Founded in 1960, the company has a long-standing reputation for engineering excellence in the cardiovascular and neurovascular markets. After being acquired by Vance Street Capital in 2017, it was sold to Spectrum Plastics Group in 2018. In 2023, Spectrum Plastics Group was acquired by DuPont, integrating Adam Spence into DuPont's healthcare portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adam Spence.